N/A
Completed N=248
Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD
Type 2 Diabetes · Chronic Kidney Diseases
Source: ClinicalTrials.gov NCT05734989 ↗
Enrolled (actual)
248
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcomePrimary: Number of Participants Who Attended or Scheduled a Primary Care Physician (PCP) Visit — 14 Participants
Summary
In Aim 1 of this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP.
In Aim 2, the investigators will implement an intervention in local health clinics to assist PCPs with screening and treating Hispanic and Black patients with diabetes.
Completion of the project will hopefully slow progression of kidney disease among Hispanic/Latino(a) and Black patients in Durham, and the information gained will allow the investigators to eventually perform the intervention on a larger scale.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Attended or Scheduled a Primary Care Physician (PCP) Visit |
14 | — |
| PRIMARY Number of Participants Who Received Urine Albumin-to-Creatinine Ratio (uACR) Screening |
40; 92 | — |
| PRIMARY Number of Participants Who Were Prescribed an SGLT2 Inhibitor (SGLT2i) and/or a GLP-1 Receptor Agonist (GLP-1 RA) |
16; 68 | — |
| PRIMARY Number of Participants Who Were Prescribed a Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) |
2; 74 | — |
Eligibility Criteria
Aim 1:
Inclusion Criteria
- Age 18 or older at time of screening
- Self-identifying as Hispanic/Latinx ethnicity.
Exclusion Criteria
- Unable to be reached by telephone
Data sourced from ClinicalTrials.gov (NCT05734989). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.